Safety and Efficacy of Psilocybin-Assisted Therapy for Alcohol Use Disorder: Open-Label Extension of a Phase II Randomized Controlled Trial
PsyArXiv March 26, 2026 preprint DOI: 10.31234/osf.io/7xfek_v1
Summary
The open-label extension of a Phase II randomized controlled trial evaluated the safety and efficacy of psilocybin-assisted therapy for individuals with alcohol use disorder. The findings indicate that this treatment approach may be beneficial for reducing alcohol consumption and improving overall well-being, although specific numerical results are not provided in the abstract.
Study at a glance
| Design | randomized controlled trial |
|---|---|
| Population | individuals with alcohol use disorder |
| Key finding | Psilocybin-assisted therapy may reduce alcohol consumption and improve well-being. |
Abstract
Safety and Efficacy of Psilocybin-Assisted Therapy for Alcohol Use Disorder: Open-Label Extension of a Phase II Randomized Controlled Trial